—A recent study suggests that perimenopausal and postmenopausal women report worse bladder health and function compared to their premenopausal counterparts. Additionally, current hormone use was ...

Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...

The FDA has received a new application for Anktiva plus BCG to treat BCG-unresponsive non–muscle invasive bladder cancer with ...

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

100% (n=7) of evaluable patients (1 CIS, 6 Ta/T1) achieved disease free status. One of these patients was re-treated at 3 months. “I am impressed by these promising NDV-01 data reported at AUA2025.